Navidea, Cardinal Health sales and marketing update

Navidea and Cardinal Health launched Lymphoseek tilmanocept in the U.S. for use in intraoperative lymphatic imaging in breast cancer and melanoma patients. Navidea priced Lymphoseek at $300 per patie...